Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.

Cancer - 1 Oct 2024

Blanc-Durand Félix, Camilleri Geraldine M, Bayle Arnaud, Aldea Mihaela, Vasseur Damien, Ouali Kaissa, Michels Judith, Pautier Patricia, Nicotra Claudio, Ngo-Camus Maud, Lacroix Ludovic, Rouleau Etienne, Ponce-Aix Santiago, Italiano Antoine, Leary Alexandra

Abstract excerpt

BACKGROUND: Molecular characterization has significantly improved the management of advanced endometrial cancer (EC). It distinguishes four molecular subclasses associated with prognosis and personalized therapeutic strategies. This study assesses the clinical utility of cell-free DNA (cfDNA) profiling in EC to identify targetable alterations. METHODS: Women with metastatic or recurrent EC were prospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell-Free Nucleic Acids

Share to Endometrial Neoplasms

Share to Liquid Biopsy

Share to Microsatellite Instability

Share to Neoplasm Recurrence, Local

Share to Prognosis

Source

Identifiers

PMID: 38824658
DOI: 10.1002/cncr.35381

Genes

TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.PMID 38824658Read ↗

High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.Semantic proximity Read ↗

ROLE OF cfDNA AND ctDNA TO IMPROVE THE RISK STRATIFICATION AND THE DISEASE FOLLOW-UP IN PATIENTS WITH ENDOMETRIAL CANCER: TOWARDS THE CLINICAL APPLICATIONSemantic proximity Read ↗

Advancing Precision Oncology: Whole-Exome Sequencing in Endometrial Cancer Liquid-Based Cytology.Semantic proximity Read ↗

Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer.Semantic proximity Read ↗

New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.Semantic proximity Read ↗

Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.Semantic proximity Read ↗

Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.Semantic proximity Read ↗

Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants.Semantic proximity Read ↗

Molecular testing for endometrial cancer: An SGO clinical practice statement.Semantic proximity Read ↗

Identification of molecular subtypes for endometrial carcinoma using a 46-gene next-generation sequencing panel: a retrospective study on a consecutive cohort.Semantic proximity Read ↗

Molecular Characterization and Clinical Implications of Endometrial Cancer.Semantic proximity Read ↗

Prognostic value of assessing ctDNA in patients with endometrial carcinoma - an international multicenter study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.